Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

It remains to be seen though if Tukysa could also be combined with Enhertu to good effect ... this setting. Seagen said no new safety signals had emerged for the combination. Pfizer reached ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

One of Pfizer’s largest deals has been the acquisition of Seagen in 2023 for $43 billion. And from the looks of it, this may very well be the deal reviving Pfizer’s fortunes. In response to ...

Pfizer’s acquisition of Seagen in December 2023 added antibody ... under the Inflation Reduction Act (IRA), which takes effect in 2025. Higher-priced drugs, including Vyndaqel, Ibrance, Xtandi ...

NEW YORK: Pfizer Inc’s proposed US$43bil (RM195bil) takeover of Seagen Inc will face an investigation ... to increase efficacy with fewer side effects. — Bloomberg ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd. (BABA), ...

Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

"We believe that the risk/benefit profile of Padcev remains unchanged," said Seagen CEO Clay Siegall on the company’s annual results call last week, noting hr that the side effects are ...